AGAlex N. Goudswaard

Alex N. Goudswaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alex N. Goudswaard has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus

    by Alex N Goudswaard, Niall J Furlong, Gerlof D Valk, Ronald P Stolk, Guy Ehm Rutten

    It is unclear whether patients with type 2 diabetes who have poor glycaemic control despite maximal oral hypoglycaemic agents (OHAs) should be commenced on insulin as monotherapy, or insulin combined with oral hypoglycaemic agents (insulin-OHA combination therapy). To assess the effects of insulin monotherapy versus insulin-OHA combinations therapy. Eligible studies were identified by searching MEDLINE, EMBASE, and The Cochrane Library. Date of last search: May 2004. Randomised controlled trials (RCTs) with 2 months minimum follow-up duration comparing insulin monotherapy (all schemes) with insulin-OHA combination therapy. Data extraction and assessment of study quality were undertaken by three reviewers in pairs. Twenty RCTs (mean trial duration 10 months) including 1,811 participants, with mean age 59.8 years and mean known duration of diabetes 9.6 years. Overall, study methodological quality was low. Twenty-eight comparisons in 20 RCTs were ordered according to clinical considerations. No studies assessed diabetes-related morbidity, mortality or total mortality. From 13 studies (21 comparisons), sufficient data were extracted to calculate pooled effects on glycaemic control. Insulin-OHA combination therapy had statistically significant benefits on glycaemic control over insulin monotherapy only when the latter was applied as a once-daily injection of NPH insulin. Conversely, twice-daily insulin monotherapy (NPH or mixed insulin) provided superior glycaemic control to insulin-OHA combination therapy regimens where insulin was administered as a single morning injection. In more conventional comparisons, regimens utilising OHAs with bedtime NPH insulin provided comparable glycaemic control to insulin monotherapy (administered as twice daily, or multiple daily injections). Overall, insulin-OHA combination therapy was associated with a 43% relative reduction in total daily insulin requirement compared to insulin monotherapy. Of the 14 studies (22 comparisons) reporting hypoglycaemia, 13 demonstrated no significant difference in the frequency of symptomatic or biochemical hypoglycaemia between insulin and combination therapy regimens. No significant differences in quality of life related issues were detected. Combination therapy with bedtime NPH insulin resulted in statistically significantly less weight gain compared to insulin monotherapy, provided metformin was used +/-sulphonylurea. In all other comparisons no significant differences with respect to weight gain were detected. Bedtime NPH insulin combined with oral hypoglycaemic agents provides comparable glycaemic control to insulin monotherapy and is associated with less weight gain if metformin is used.


  • Patient Characteristics do not Predict Poor Glycaemic Control in type 2 Diabetes Patients Treated in Primary Care

    by Alex N. Goudswaard, Ronald P. Stolk, Peter Zuithoff, Guy E.H.M. Rutten

    Many diabetic patients in general practice do not achieve good glycaemic control. The aim of this study was to assess which characteristics of type 2 diabetes patients treated in primary care predict...


  • Long‐term effects of self‐management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care

    by A. N. Goudswaard, R. P. Stolk, N. P. A. Zuithoff, H. W. De Valk, G. E. H. M. Rutten

    Aims  Education is an essential part of the management of patients with Type 2 diabetes, but the long‐term effects are unclear and not well investigated in primary care.Methods  Fifty‐four patients (39–75 years) treated with maximal dosages of oral hypoglycaemic agents, needing to start insulin (HbA1c≥ 7.0%), were randomly allocated to a 6‐month educational programme by a diabetes nurse (DN group) or usual care (UC group). Main outcome measures were HbA1c, number of patients with HbA1c < 7.0%, and number of patients treated with insulin 18 months after baseline.Results  Six weeks after the intervention HbA1c levels had improved from 8.2 (1.1) to 7.2 (1.3) in the DN group, and from 8.8 (1.5) to 8.4 (1.7) in the UC group. Adjusted for baseline values, at 6 weeks HbA1c improved 0.7% (95% confidence interval 0.1, 1.4) more in DN than in UC. Of the patients in DN, 60% reached HbA1c < 7.0% compared with 17% in UC (P < 0.01). However, at 18 months there were no significant differences for HbA1c, number of patients with HbA1c < 7.0%, or number treated with insulin.Conclusions  Education was effective in improving glycaemic control and in delaying the need for insulin therapy in patients treated with maximal oral hypoglycaemic therapy. The reduced effect after 1 year was probably due to the discontinuation of the educational programme. Short‐term education should not be offered without regular reinforcements integrated into standard diabetes care.


  • Improving glycaemic control in patients with Type 2 diabetes mellitus without insulin therapy

    by A. N. Goudswaard, R. P. Stolk, H. W. De Valk, G. E. H. M. Rutten

    Aims In general practice at least 30% of those with Type 2 diabetes do not achieve good glycaemic control. We studied the effect of improving oral glucose‐lowering medication in a primary care setting in patients treated with oral hypoglycaemic agents without satisfactory glycaemic control.Methods We provided flowcharts to general practitioners and outreach visits by trained facilitators, who checked adherence to the protocol. Fifty‐two Dutch general practices with 2140 Type 2 diabetes mellitus (DM) patients recruited 288 patients ≤ 75 years old inadequately controlled (HbA1c > 7%) by diet or oral medication. Outcome measures were decrease of HbA1c, number of patients with HbA1c ≤ 7%, and non‐compliance rate.Results After a mean of 3.3 consultations over 14 weeks, 209 patients were following the protocol fully with a reduction in HbA1c from 8.7% to 6.7% (P < 0.001). One hundred and fifty‐eight patients (55%) achieved HbA1c≤ 7%, and 51 (18%) persisted with HbA1c > 7% unless fasting blood glucose ≤ 7 mmol/l (n = 18) or a maximum of medication (n = 33). Seventy‐nine patients (27%) did not adhere to the protocol, mostly due to loss of motivation and non‐attendance.Conclusions A simple flowchart and relatively little support by trained facilitators results in improved glycaemic control.Diabet. Med. 20, 540–544 (2003)


  • Open Access

    Quality of recording of data from patients with type 2 diabetes is not a valid indicator of quality of care. A cross-sectional study

    by Alex N Goudswaard, Kahnh Lam, Ronald P Stolk, Guy Ehm Rutten

    Background. The quality of recording of clinical data in diabetes care in general practices is very variable. It has been suggested that better recording leads to improved glycaemic control. Objectives. The purpose of this study was to assess the completeness of recording by GPs of data from type 2 diabetes patients; to compare recorded and missing data; and to investigate the association between completeness and glycaemic control. Methods. A cross-sectional survey was carried out in 52 general practices. Medical records were scrutinized for the presence of 11 variables. Examining patients through an active approach completed incomplete records. We compared recorded and unrecorded items. Completeness of recording was determined at both patient and practice levels. Results. Fifty-two general practices with 1641 type 2 diabetes patients cared for by the GP participated. The frequency of absence of any particular item ranged from 20 to 70%. Weight, systolic blood pressure and HbA1c were slightly lower in patients with those items missing on their files, and more such patients were non-smokers (P < 0.05). The percentage of patients with unrecorded variables that exceeded target values ranged from 39 to 75. Neither at practice level nor at patient level was any association between the completeness of the data recording and HbA1c found. Conclusion. Records often were incomplete, which hampers a systematic approach to care of diabetic patients. However, the lack of association between completeness of data recording and control of glycaemia indicates that improved recording is not a valid indicator of good quality of care.